Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The JAMM domain zinc metalloprotease is a unique class of deubiquitinating enzymes (DUBs) characterized by a zinc-dependent metalloprotease mechanism and a conserved sequence motif (EX(n)HS/THX(7)SXXD). These enzymes are critical in the removal of ubiquitin (and ubiquitin-like proteins such as NEDD8) from substrate proteins, a process essential for regulating the ubiquitin-proteasome pathway, protein turnover, and proteasome activity. The JAMM domain (also known as the JAB1/MPN/Mov34 motif) is found in multiple essential eukaryotic proteins, such as Rpn11 (in the 19S proteasome) and Csn5 (in the COP9 signalosome), where it orchestrates the terminal steps of protein degradation by removing ubiquitin prior to substrate proteolysis[6][4][1]. The mechanism involves catalytic hydrolysis of the isopeptide bond via a zinc-mediated nucleophilic attack, similar to but structurally distinct from classical thermolysin-like metalloproteases[1][3][6]. Dysregulation and mutation of JAMM domain proteins are implicated in tumorigenesis and other disorders, making the JAMM domain an actively pursued therapeutic target in oncology and immunology, with small-molecule inhibitors under development[4][6][1].
Competitive inhibition at the catalytic zinc site of the JAMM domain; Coordination or chelation of Zn^2+ in the active site to block enzymatic activity; Interference with protein deubiquitination/deNEDDylation, thereby affecting protein degradation pathways
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on JAMM domain zinc metalloprotease (JAMM (JAB1/MPN/Mov34 metalloenzyme)).